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Summary We investigated the effect of chronic cigarette smoking on the expression
of haem-oxygenase (HO)-1 and HO-2. Normal subjects and asymptomatic young
current smokers with normal lung function tests underwent bronchoalveolar lavage
for recovery of macrophages. Reverse transcription/polymerase chain reaction (RT-
PCR) analysis showed no significant difference in HO-1 and HO-2 mRNA expression
between the two groups. On the other hand, Western blot analysis showed a
significant (Po0:05) reduction of HO-2 protein, but not of HO-1, in alveolar
macrophages from smokers compared to normal. There was no significant
differences by immunocytochemistry for HO-1 and HO-2 expression between the
groups. We concluded that HO-2 expression is reduced in alveolar macrophages of
smokers, possibly due to the oxidative stress of cigarette smoke. This may in turn
lead to reduced protection against further oxidative insults.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
The airway epithelium is continuously exposed to
oxidants inhaled from exogenous sources, such as
cigarette smoke and ozone,1,2 or endogenously
produced and released from neutrophils and alveo-
lar macrophages recruited to the lungs and acti-
vated during acute and chronic airway
inflammation.3 Oxidative stress has been impli-
cated in the pathogenesis of many respiratory
diseases including chronic obstructive pulmonary
disease (COPD), bronchial asthma and cystic fibro-
sis.4,5 There is accumulating evidence that oxida-
tive stress may play an important role in the
pathogenesis of COPD. There is an increase in the
concentration of hydrogen peroxide in the exhaled
breath condensates of patients with COPD, parti-
cularly during exacerbations,6 and increased breath
and urinary concentrations of 8-isoprostane, a
marker of oxidative stress.5 Oxidative stress may
exacerbate COPD through several mechanisms,
including the activation of the transcription factor,
nuclear factor-kB (NF-kB), which switches on the
genes for TNF-a; interleukin-8, and other inflam-
matory proteins, and oxidative damage of anti-
proteases, such as a1-antitrypsin and secretory
leukoprotease inhibitor, thus enhancing inflamma-
tion and proteolytic injury.5 Chronic inhalation of
tobacco smoking is the main cause of COPD around
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the world.7 In vitro acute exposure to tobacco
smoke induces the expression of haem-oxygenase-1
through reactive oxygen intermediates.8 Many
studies indicate that the haem-oxygenase (HO)
enzyme system is involved in the lung resistance
against oxidative damage.9–11
Haem-oxygenases catalyse the rate-limiting step
in the oxidative degradation of haem to biliverdin,
which is then converted to the antioxidant bilir-
ubin, carbon monoxide (CO), and free iron. Three
isoforms called HO-1, HO-2, and HO-3 have been
characterised.12 While HO-2 is constitutively ex-
pressed in most cells, HO-1 is inducible by many
agents that lead to oxidative stress, including
hydrogen peroxide and heavy metals such as
cadmium.13,14 The HO-3 expression and function
has not been fully characterised.15 It has been
proposed that HO-1 plays an important role in lung
protection against oxidant injury,16,17 but studies
using knock-out mice suggest also an important role
of HO-2 in the protection of the lungs against
oxidative stress.10
Carbon monoxide (CO) generated by catalysis of
haem by HO detectable in the exhaled air and
elevated levels of exhaled CO have been reported
in stable asthma.6 The difference in exhaled CO
between normal and asthmatic subjects, however,
is much less than that of exhaled nitric oxide.18 The
inducible isoenzyme HO-1 expression in the airways
has been already extensively studied both in the
bronchoalveolar lavage (BAL) cells and in the
bronchial mucosa from normal subjects and asth-
matics patients.19,18 Constitutive isoenzyme HO-2
expression has been described in the bronchial
epithelium of normal subjects and asthmatics
patients.18 However, the expression of the two
isoforms of the HO system has not been examined
in the alveolar macrophages from smokers. We
hypothesised that the expression of inducible HO-1
would be increased in cigarette smokers. We
therefore investigated the expression of HO-1 and
HO-2 in bronchoalveolar lavage macrophages col-
lected from normal subjects and young current
asymptomatic smokers.
Methods
Patients
Six healthy smokers and six normal nonsmoking
volunteers were studied (Table 1). The healthy
smokers were current smokers (45 pack/yr; 20–30
cigarettes per day) with a normal forced expiratory
volume in one second (FEV1) and no respiratory
symptoms. All study subjects were free of acute
upper respiratory tract infections and none had
received glucocorticoids, theophylline or antibio-
tics within the preceding month. All subjects had
no past history of asthma or allergic rhinitis. The
study was approved by the local Ethics Committee,
and informed consent was obtained from each
subject.
Fibreoptic bronchoscopy, collection and
processing of bronchoalveolar lavage
Subjects attended the bronchoscopy suite at 8.30
a.m. after having fasted from midnight and were
pre-treated with atropine (0.6mg IV) and midazo-
lam (5–10mg IV). Oxygen (3 l/min) was adminis-
tered via nasal prongs throughout the procedure
and oxygen saturation was monitored with a digital
oximeter. Using local anaesthesia with lidocaine
(4%) to the upper airways and larynx, a fibreoptic
bronchoscope (Olympus BF10 Key-Med, Southend,
UK) was passed through the nasal passages into the
trachea. Further lidocaine (2%) was sprayed into
the lower airways. The bronchoscope was wedged
in a right middle lobe bronchus and sterile saline
solution at 371C was injected in five aliquots of
50ml each. The fluid was gently suctioned back and
collected in a conical polypropylene tubes kept
on ice.
Preparation of BAL cells
BAL fluid was strained through sterile gauze
to remove mucus and the cells collected by
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Table 1 Patient characteristics.
n Age (years) Gender Atopyn FEV1 (% pred) FEV1/FVC (%) Pack-year
w
Non-smoker 6 25.772.6 6M 1/6 9774.1 88.271.1 0
Smoker 6 27.773.9 4M 2/6 8474.9 88.370.7 12.873.8
Data shown as mean7SEM.
FEV1: Forced expiratory volume in one sec; FVC: Forced expiratory volume; M: Male.
nAtopy was defined as positive response to skin prick tests to common aeroallergens.
wOne pack-year of cigarette smoking is one year of smoking 20 cigarettes per day.
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centrifugation. The cell pellet was resuspended in
Hanks’ balanced salt solution. The total number of
cells was counted in a B .urker chamber and the
viability was tested by exclusion of trypan blue.
5 106 cells/well were cultured on 6-well plates at
371C, 5% CO2 for 1 h in 1ml/well of sterile Dulbecco
modified Eagle’s medium (DMEM; Sigma, Poole, UK)
supplemented with fetal calf serum (10%), benzyl-
penicillin (0.1mg/ml), streptomycin sulphate
(0.1mg/ml) and L-glutamine. Nonadherent cells
were removed by washing the monolayers with
371C culture medium, yielding monolayers that
contained at least 95% macrophages by morpholo-
gic profile. Cells for western blot analysis were
immediately placed on ice and processed as
described later. Cytospin slides were prepared
and were dried for 30min. Slides were wrapped in
aluminum foil and stored at 701C prior to
immunostaining.
RNA extraction and reverse transcriptase
polymerase chain reaction (RT-PCR)
RNA was isolated from alveolar macrophages using
the Qiagen RNeasy mini kit according to the
manufacturer’s instructions. Reverse transcription
(RT) was performed on 0.5 mg of RNA. RNA was
heated to 701C for 5min and then mixed with
0.01 mg/ml random primers, 1.0mM dNTP, 1 mg/ml
RNAsin, 0.25 mg/ml AMV-reverse transcriptase, in
1 reverse transcriptase buffer and incubated at
421C for 1 h followed by denaturation at 901C for
4min. The resultant complementary DNA (cDNA)
was then diluted by the addition of 80 ml of water.
For polymerase chain reaction (PCR), 5 ml of cDNA
were incubated in a final volume of 25 ml containing
1 KCl buffer, 2mM dNTP, 5 ng/ml specific primers,
and Taq polymerase 2U. Specific primers for HO-1
gave a specific product of 440 bp: forward primer,
50-ATCCCCCAGGATTTGTCAGAG-30; reverse primer,
50-AGGGCTTTCTGGGCAATCTTT-30: The cycles used
were 941 for 30 s, 621 for 30 s, 721 for 1min for 26
cycles followed by 721 for 10min. Specific primers
for HO-2 gave a specific product of 523 bp: forward
primer 50-GGAAGGGACCAAGGAAGCACA-30; reverse
primer, 50-GTTCAGGTCCAGGGCGTTCAT-30: The cy-
cles used were 941 for 30 s, 701 for 30 s, 721 for
1min for 27 cycles followed by 721 for 10min. RT-
PCR of glyceraldehydes-3-phosphate dehydrogen-
ase (GAPDH) was performed to act as an internal
control and the specific primers used gave a PCR
product of 589 bp: forward primer, 50-CCACC-
CATGGCAAATTCCATGGCA-30; reverse primer, 5-
TCTAGACGGCAGGCTAGGTCCACC-3. The cycles
used were 941 for 30 s, 601 for 30 s, 721 for 1min
for 24 cycles followed by 721 for 10min. PCR
products were identified on 2wt/vol% agarose gels.
Samples that did not contain reverse transcriptase
were used as negative controls. The intensity of
bands for PCR was measured densitometrically
using UVP Gel works documentation system
GDS800 (UVP, Cambridge, UK).
Western blot analysis for HO-1 and HO-2
protein
Whole-cell proteins were extracted from alveolar
macrophages. At least 50 mg/lane of whole-cell
proteins were subjected to a 18% SDS-polyacryla-
mide gel electrophoresis, and transferred to nitro-
cellulose filters (Hybond-ECL, Amersham Pharmacia
Biotech) by blotting. Filters were blocked for
45min at room temperature in TBS, 0.05% Tween
20, 5% nonfat dry milk. The filters were then
incubated with goat antihuman HO-1 (C-20, sc-
7695), -2(C-20, sc-7697) antibody (Santa Cruz
Biotechnology, USA) for 1 h at room temperature
in TBS, 0.05% Tween 20, 5% nonfat dry milk at
dilution of 1:1000. These antibodies are specific for
the respective human HO proteins and do not cross-
react each other. Filters were washed three times
in TBS, 0.05% Tween 20 and then incubated for
45min at room temperature with antigoat antibody
conjugated to horseradish peroxidase (Dako, UK) in
TBS, 0.05% Tween 20, 5% nonfat dry milk, at
dilution of 1:4000. After further three washes in
TBS, 0.05% Tween 20 visualisation of the immuno-
complexes was performed using ECL as recom-
mended by the manufacturer (Amersham
Pharmacia Biotech, UK). As an internal control we
reprobed each filter with an antihuman actin
antibody (Santa Cruz Biotechnology, USA). The
bands, which were visualised at approximately
43 kDa (actin), 32 kDa (HO-1) and 35 kDa (HO-2)
were quantified using a densitometer with Grab-It
and GelWorks software (UVP, Cambridge, UK). The
individual band optical density values for each lane
of HO-1 and -2 were expressed as the ratio with the
corresponding actin optical density value of the
same lane.
Immunoperoxidase staining for HO-1 and HO-
2 in alveolar macrophages
Cytospins of alveolar macrophages were fixed with
cold methanol. Cytospins were washed repeatedly
with phosphate-buffered saline (PBS). The cell
membranes were permeabilised by adding to the
blocking serum 0.3% triton X-100. Endogenous
peroxidase activity was blocked by incubating
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slides in 3% hydrogen peroxide (H2O2) and 0.02%
sodium azide in methanol for 1 h, followed by
washing in PBS. Nonspecific labelling was blocked
by coating with blocking serum (5% normal rabbit
serum) for 20min at room temperature. After
washing in PBS the cells were incubated for 1 h
with goat polyclonal antihuman HO-1, -2 antibody
(Santa Cruz Biotechnology) at dilutions of 1:50 of a
200 mg/ml solution. For the negative control slides,
in some slides normal goat nonspecific immunoglo-
bulins (Santa Cruz Biotechnology) were used at the
same protein concentration as the primary anti-
body. After repeated washing steps with PBS, the
sections were subsequently incubated with anti-
goat biotinylated antibody (Vector Elite ABC Kit,
Vector Laboratories) for 30min at room tempera-
ture. After further washing the sections were
subsequently incubated with ABC reagent (Vector
Elite ABC Kit, Vector Laboratories) for 30min at
room temperature. Slides were then incubated
with chromogen-fast diaminobenzidine (DAB) for 1–
5min, after which they were counterstained in
hematoxylin and mounted on mounting medium
(DPX).
Data analysis
Group data were expressed as mean7standard
error of the mean (SEM). Differences between
groups were analysed using unpaired t-test. Prob-
ability values of Po0:05 were considered as
significant. Data analysis was performed using the
Stat View SE Graphics program (Abacus Concepts
Inc., Berkeley, CA-USA).
Results
RT-PCR expression of HO-1 and HO-2 mRNA
RT-PCR analysis of HO-1 and HO-2 mRNA expression
in BAL macrophages showed no significant differ-
ence in HO-1 and HO-2 mRNA between normal and
cigarette smokers subjects (Fig. 1).
Analysis of HO-1 and HO-2 protein
expression
Western blot analysis of the alveolar macrophages
showed that there was a significant reduction of
the expression of HO-2 protein in alveolar macro-
phages from smokers compared with normal
(Fig. 2). However, no significant differences were
observed in HO-1 protein expression between
normal subjects and smokers. Immunocytochemical
staining for HO-1 and HO-2 proteins on cytospins of
alveolar macrophages revealed staining in alveolar
macrophages of normal subjects and smokers, but
there was no obvious difference in the intensity of
the staining (Fig. 3).
Discussion
In this study we have examined the expression of
the 2 main isoenzymes of the HO system, HO-1 and
HO-2, in alveolar macrophages from normal sub-
jects and asymptomatic current smokers with
normal lung function. We found a large expression
of HO-1 both in normal subjects and smokers with
no significant differences between the two groups.
This suggests that in the airways of the normal
subjects and smokers there is an active HO system
to protect against environmental oxidative stress.
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Figure 1 RT-PCR analysis of HO-1 and HO-2 mRNA
expression in human alveolar macrophages of 5 normal
subjects and 6 asymptomatic smokers. The specific HO-1
and HO-2 PCR product was detected in alveolar macro-
phages as 440 and 523 base-pair products, respectively
(Panel A). GAPDH product is also shown to demonstrate
equal loading. The mean HO-1 and HO-2 expression, as
measured by densitometric analysis, is shown in panel B,
expressed as a ratio of GAPDH. There was no significant
difference between the normal and smokers.
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In vitro studies have previously demonstrated that
HO-2 is a constitutive isoenzyme, whereas HO-1 is
an inducible form that is not usually expressed in
unstimulated airway epithelial cells.11 In vitro HO-1
expression can be induced in many cells by
different stimuli, particularly those that induce
oxidative stress.17 There is evidence for increased
oxidative stress in the lungs of young current
smokers with normal lung function and of older
patients with COPD.20 However in our study we
found no increase in the expression of HO-1 mRNA
and protein in alveolar macrophages of smokers
compared with normal subjects. One possible
explanation of these results is that the expression
of this enzyme is already maximal due to the
continuous stimulation by the environmental oxi-
dative stresses, such as exposure to air pollutants.
Basal expression of HO-1 has been described in
hamster fibroblasts and this constitutive HO-1
expression was associated with resistance to
hyperoxia.21 The variable oxidant and antioxidant
effect of HO-1 in the different models may depend
on the level of its expression.10
By contrast, we found a significant decrease of
HO-2 protein expression in alveolar macrophages of
young current smokers with normal lung function
compared with normal subjects using Western blot
analysis, which is a more sensitive assay for
detection of differences in the total amount of a
protein than immunocytochemistry. The functional
significance of this HO-2 protein decrease is not
known. HO-2 expression in the lungs may provide
cellular protection against oxidant injury.10
In a model of HO-2 knock-out mice, the animals
were more susceptible to oxidative stress toxi-
city, despite an increase in HO-1.10 In this
model, HO-1 induction may be simply a genera-
lised response to oxidative stress, and not necessa-
rily protective. The increased oxygen toxicity
in the knockout mice also suggests that HO-2
provides an essential protective function that
may be important in antioxidant defence over
and above the effects of HO-1. The increased
toxicity in absence of HO-2 appears to be corre-
lated to the accumulation in the lungs of haem-
induced iron.10
In summary, we examined the expression of HO-1
and HO-2 isoenzymes in alveolar macrophages of
normal subjects and smokers with normal lung
function, and found a reduction in HO-2 protein
expression. HO-2 deficiency in the alveolar macro-
phages of smokers may indicate that the lung of
smokers may be less well protected against
oxidative stress. Whether this deficiency can lead
to the development of COPD deserves further
study.
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Figure 2 Representative Western blot analyses of HO-1
(panel A) and HO-2 (panel B) protein expression (with the
respective b-actin controls) in macrophages of 3 normal
subjects (N1, N2, N3) and asymptomatic smokers (S1, S2,
S3). Panel C shows the mean expression of HO-1 and HO-2
as a ratio of b-actin. There is no significant difference in
the expression of HO-1, but HO-2 expression was
significantly reduced in smokers (S) compared to non-
smokers (N). Results are shown as mean7SEM of 6
individuals in each group. Po0:05:
Neg Control
Smoker
Normal
HO-1 HO-2
Figure 3 Representative immunocytochemical analysis
of HO-1 (left panels) and HO-2 (right panels) expression
in macrophages of normal subjects and asymptomatic
smokers. Immunocytochemical staining for HO-1 and HO-
2 protein was found in macrophages of both nonsmokers
and smokers. Negative control shows no immunostaining.
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